186 related articles for article (PubMed ID: 18628459)
1. Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.
Nadler Y; Camp RL; Schwartz C; Rimm DL; Kluger HM; Kluger Y
Clin Cancer Res; 2008 Jul; 14(14):4455-62. PubMed ID: 18628459
[TBL] [Abstract][Full Text] [Related]
2. High HSP90 expression is associated with decreased survival in breast cancer.
Pick E; Kluger Y; Giltnane JM; Moeder C; Camp RL; Rimm DL; Kluger HM
Cancer Res; 2007 Apr; 67(7):2932-7. PubMed ID: 17409397
[TBL] [Abstract][Full Text] [Related]
3. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.
Nadler Y; González AM; Camp RL; Rimm DL; Kluger HM; Kluger Y
Ann Oncol; 2010 Mar; 21(3):466-473. PubMed ID: 19717535
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer.
Nadler Y; Camp RL; Giltnane JM; Moeder C; Rimm DL; Kluger HM; Kluger Y
Breast Cancer Res; 2008; 10(2):R35. PubMed ID: 18430249
[TBL] [Abstract][Full Text] [Related]
5. Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer.
Ali HR; Dawson SJ; Blows FM; Provenzano E; Pharoah PD; Caldas C
Br J Cancer; 2012 May; 106(11):1798-806. PubMed ID: 22538974
[TBL] [Abstract][Full Text] [Related]
6. Elevated Aurora B expression contributes to chemoresistance and poor prognosis in breast cancer.
Zhang Y; Jiang C; Li H; Lv F; Li X; Qian X; Fu L; Xu B; Guo X
Int J Clin Exp Pathol; 2015; 8(1):751-7. PubMed ID: 25755770
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.
Chen YJ; Chen CM; Twu NF; Yen MS; Lai CR; Wu HH; Wang PH; Yuan CC
Virchows Arch; 2009 Nov; 455(5):431-40. PubMed ID: 19838728
[TBL] [Abstract][Full Text] [Related]
8. Expression of mitotic kinases phospho-aurora A and aurora B correlates with clinical and pathological parameters in bladder neoplasms.
Bufo P; Sanguedolce F; Tortorella S; Cormio L; Carrieri G; Pannone G
Histol Histopathol; 2010 Nov; 25(11):1371-7. PubMed ID: 20865660
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer.
Yamamoto S; Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Iwase H
BMC Cancer; 2013 Apr; 13():217. PubMed ID: 23627634
[TBL] [Abstract][Full Text] [Related]
10. Expression of aurora kinase A and B in chondrosarcoma and its relationship with the prognosis.
Liang X; Wang D; Wang Y; Zhou Z; Zhang J; Li J
Diagn Pathol; 2012 Jul; 7():84. PubMed ID: 22809428
[TBL] [Abstract][Full Text] [Related]
11. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
McCarthy MM; Sznol M; DiVito KA; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jul; 11(14):5188-94. PubMed ID: 16033835
[TBL] [Abstract][Full Text] [Related]
13. Expression of cell-cycle regulatory proteins BUBR1, MAD2, Aurora A, cyclin A and cyclin E in invasive ductal breast carcinomas.
Du J; Du Q; Zhang Y; Sajdik C; Ruan Y; Tian XX; Fang WG
Histol Histopathol; 2011 Jun; 26(6):761-8. PubMed ID: 21472690
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer.
Bauer M; Eickhoff JC; Gould MN; Mundhenke C; Maass N; Friedl A
Breast Cancer Res Treat; 2008 Apr; 108(3):389-97. PubMed ID: 17554627
[TBL] [Abstract][Full Text] [Related]
15. High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas.
Araki K; Nozaki K; Ueba T; Tatsuka M; Hashimoto N
J Neurooncol; 2004; 67(1-2):53-64. PubMed ID: 15072448
[TBL] [Abstract][Full Text] [Related]
16. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
17. Aurora kinases as prognostic biomarkers in ovarian carcinoma.
Mendiola M; Barriuso J; Mariño-Enríquez A; Redondo A; Domínguez-Cáceres A; Hernández-Cortés G; Pérez-Fernández E; Sánchez-Navarro I; Vara JA; Suárez A; Espinosa E; González-Barón M; Palacios J; Hardisson D
Hum Pathol; 2009 May; 40(5):631-8. PubMed ID: 19157502
[TBL] [Abstract][Full Text] [Related]
18. Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.
Pannone G; Hindi SA; Santoro A; Sanguedolce F; Rubini C; Cincione RI; De Maria S; Tortorella S; Rocchetti R; Cagiano S; Pedicillo C; Serpico R; Lo Muzio L; Bufo P
Int J Immunopathol Pharmacol; 2011; 24(1):79-88. PubMed ID: 21496390
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Aurora A kinase expression in breast cancer: a tool for early diagnosis?
Ferchichi I; Sassi Hannachi S; Baccar A; Marrakchi Triki R; Cremet JY; Ben Romdhane K; Prigent C; Ben Ammar El Gaaied A
Dis Markers; 2013; 34(2):63-9. PubMed ID: 23324574
[TBL] [Abstract][Full Text] [Related]
20. Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.
Putluri N; Maity S; Kommagani R; Creighton CJ; Putluri V; Chen F; Nanda S; Bhowmik SK; Terunuma A; Dorsey T; Nardone A; Fu X; Shaw C; Sarkar TR; Schiff R; Lydon JP; O'Malley BW; Ambs S; Das GM; Michailidis G; Sreekumar A
Neoplasia; 2014 May; 16(5):390-402. PubMed ID: 25016594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]